カテゴリー： QYResearch, 世界

網膜疾患治療薬の世界市場：規模・現状・予測

◆英語タイトル：Global Retinal Disease Therapeutics Market Size, Status and Forecast 2019-2025
◆商品コード：DATA909X18915
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月25日（※2024年版があります。お問い合わせください）
◆ページ数：96
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,900 ⇒換算￥577,200	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,850 ⇒換算￥865,800	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,800 ⇒換算￥1,154,400	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、網膜疾患治療薬の世界市場について調査・分析し、網膜疾患治療薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（黄斑変性症、糖尿病黄斑浮腫、糖尿病網膜症、網膜静脈閉塞）、用途別（病院薬局、小売薬局、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の網膜疾患治療薬市場動向
・主要企業別マーケットシェア
・網膜疾患治療薬の種類別市場規模2014-2019
（黄斑変性症、糖尿病黄斑浮腫、糖尿病網膜症、網膜静脈閉塞）
・網膜疾患治療薬の用途別市場規模2014-2019
（病院薬局、小売薬局、その他）
・網膜疾患治療薬の北米市場：主要企業・種類別/用途別市場規模
・網膜疾患治療薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・網膜疾患治療薬の中国市場：主要企業・種類別/用途別市場規模
・網膜疾患治療薬の日本国内市場：主要企業・種類別/用途別市場規模
・網膜疾患治療薬の東南アジア市場：主要企業・種類別/用途別市場規模
・網膜疾患治療薬のインド市場：主要企業・種類別/用途別市場規模
・網膜疾患治療薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Merck、Novartis、Allergan、Roche、Regeneron、Santen）
・網膜疾患治療薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

【レポートの概要】

Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.In 2018, the global Retinal Disease Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Retinal Disease Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Disease Therapeutics development in North America, Europe and Asia-Pacific.

The key players covered in this study
Merck
Novartis
Allergan
Roche
Regeneron
Santen
…

Market segment by Type, the product can be split into
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion

Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Others

Market segment by Regions/Countries, this report covers
North America
Europe
Asia-Pacific

The study objectives of this report are:
To analyze global Retinal Disease Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Retinal Disease Therapeutics development in North America, Europe and Asia-Pacific.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Disease Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Macular Degeneration
1.4.3 Diabetic Macular Edema
1.4.4 Diabetic Retinopathy
1.4.5 Retinal Vein Occlusion
1.5 Market by Application
1.5.1 Global Retinal Disease Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinal Disease Therapeutics Market Size
2.2 Retinal Disease Therapeutics Growth Trends by Regions
2.2.1 Retinal Disease Therapeutics Market Size by Regions (2019-2025)
2.2.2 Retinal Disease Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Retinal Disease Therapeutics Market Size by by Players
3.1.1 Global Retinal Disease Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Retinal Disease Therapeutics Key Players Head office and Area Served
3.3 Key Players Retinal Disease Therapeutics Product/Solution/Service
3.4 Date of Enter into Retinal Disease Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinal Disease Therapeutics Market Size by Type (2014-2019)
4.2 Global Retinal Disease Therapeutics Market Size by Application (2014-2019)

5 North America
5.1 North America Retinal Disease Therapeutics Market Size (2014-2019)
5.2 Retinal Disease Therapeutics Key Players in North America
5.3 North America Retinal Disease Therapeutics Market Size by Type
5.4 North America Retinal Disease Therapeutics Market Size by Application

6 Europe
6.1 Europe Retinal Disease Therapeutics Market Size (2014-2019)
6.2 Retinal Disease Therapeutics Key Players in Europe
6.3 Europe Retinal Disease Therapeutics Market Size by Type
6.4 Europe Retinal Disease Therapeutics Market Size by Application

7 Asia-Pacific
7.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2014-2019)
7.2 Retinal Disease Therapeutics Key Players in Asia-Pacific
7.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Type
7.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Application

8 International Players Profiles
8.1 Merck
8.1.1 Merck Company Details
8.1.2 Company Description and Business Overview
8.1.3 Retinal Disease Therapeutics Introduction
8.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2014-2019))
8.1.5 Merck Recent Development
8.2 Novartis
8.2.1 Novartis Company Details
8.2.2 Company Description and Business Overview
8.2.3 Retinal Disease Therapeutics Introduction
8.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2014-2019)
8.2.5 Novartis Recent Development
8.3 Allergan
8.3.1 Allergan Company Details
8.3.2 Company Description and Business Overview
8.3.3 Retinal Disease Therapeutics Introduction
8.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2014-2019)
8.3.5 Allergan Recent Development
8.4 Roche
8.4.1 Roche Company Details
8.4.2 Company Description and Business Overview
8.4.3 Retinal Disease Therapeutics Introduction
8.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2014-2019)
8.4.5 Roche Recent Development
8.5 Regeneron
8.5.1 Regeneron Company Details
8.5.2 Company Description and Business Overview
8.5.3 Retinal Disease Therapeutics Introduction
8.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2014-2019)
8.5.5 Regeneron Recent Development
8.6 Santen
8.6.1 Santen Company Details
8.6.2 Company Description and Business Overview
8.6.3 Retinal Disease Therapeutics Introduction
8.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2014-2019)
8.6.5 Santen Recent Development

9 Market Forecast 2019-2025
9.1 Market Size Forecast by Product (2019-2025)
9.2 Market Size Forecast by Application (2019-2025)
9.3 Market Size Forecast by Regions
9.4 North America
9.5 Europe
9.6 Asia-Pacific

10 Analyst’s Viewpoints/Conclusions

11 Appendix
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.1.1 Research Programs/Design
11.1.1.2 Market Size Estimation
11.1.1.3 Market Breakdown and Data Triangulation
11.1.2 Data Source
11.1.2.1 Secondary Sources
11.1.2.2 Primary Sources
11.2 Disclaimer
11.3 Author Details

List of Tables and Figures

Table Retinal Disease Therapeutics Key Market Segments
Table Key Players Retinal Disease Therapeutics Covered
Table Global Retinal Disease Therapeutics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Macular Degeneration Figures
Table Key Players of Macular Degeneration
Figuer Diabetic Macular Edema Figures
Table Key Players of Diabetic Macular Edema
Figuer Diabetic Retinopathy Figures
Table Key Players of Diabetic Retinopathy
Figuer Retinal Vein Occlusion Figures
Table Key Players of Retinal Vein Occlusion
Table Global Retinal Disease Therapeutics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Retinal Disease Therapeutics Market Share by Application in 2018 & 2025
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacy Case Studies
Figure Others Case Studies
Figure Retinal Disease Therapeutics Report Years Considered
Figure Global Retinal Disease Therapeutics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Retinal Disease Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Retinal Disease Therapeutics Market Size by Regions 2019-2025 (Million US$)
Table Global Retinal Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Retinal Disease Therapeutics Market Share by Regions 2014-2019
Figure Global Retinal Disease Therapeutics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Retinal Disease Therapeutics Revenue by by Players (2014-2019) (Million US$)
Table Global Retinal Disease Therapeutics Market Share by by Players (2014-2019)
Figure Global Retinal Disease Therapeutics Market Share by by Players in 2018
Table Global Retinal Disease Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Retinal Disease Therapeutics Product/Solution/Service
Table Date of Enter into Retinal Disease Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Retinal Disease Therapeutics Market Size by Type (2014-2019) (Million US$)
Table Global Retinal Disease Therapeutics Market Size Share by Type (2014-2019)
Figure Global Retinal Disease Therapeutics Market Size Market Share by Type (2014-2019)
Table Global Retinal Disease Therapeutics Market Size by Application (2014-2019) (Million US$)
Table Global Retinal Disease Therapeutics Market Size Share by Application (2014-2019)
Figure Global Retinal Disease Therapeutics Market Size Market Share by Application (2014-2019)
Figure Global Retinal Disease Therapeutics Revenue Market Share by Application in 2018
Figure North America Retinal Disease Therapeutics Market Size 2014-2019 (Million US$)
Table North America Key Players Retinal Disease Therapeutics Revenue (2018-2019) (Million US$)
Table North America Key Players Retinal Disease Therapeutics Market Share (2018-2019)
Table North America Retinal Disease Therapeutics Market Size by Type 2014-2019 (Million US$)
Table North America Retinal Disease Therapeutics Market Share by Type 2014-2019
Table North America Retinal Disease Therapeutics Market Size by Application 2014-2019 (Million US$)
Table North America Retinal Disease Therapeutics Market Share by Application 2014-2019
Figure Europe Retinal Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Europe Key Players Retinal Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Europe Key Players Retinal Disease Therapeutics Market Share (2018-2019)
Table Europe Retinal Disease Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Europe Retinal Disease Therapeutics Market Share by Type 2014-2019
Table Europe Retinal Disease Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Europe Retinal Disease Therapeutics Market Share by Application 2014-2019
Figure Asia-Pacific Retinal Disease Therapeutics Market Size 2014-2019 (Million US$)
Table Asia-Pacific Key Players Retinal Disease Therapeutics Revenue (2018-2019) (Million US$)
Table Asia-Pacific Key Players Retinal Disease Therapeutics Market Share (2018-2019)
Table Asia-Pacific Retinal Disease Therapeutics Market Size by Type 2014-2019 (Million US$)
Table Asia-Pacific Retinal Disease Therapeutics Market Share by Type 2014-2019
Table Asia-Pacific Retinal Disease Therapeutics Market Size by Application 2014-2019 (Million US$)
Table Asia-Pacific Retinal Disease Therapeutics Market Share by Application 2014-2019
Table Merck Company Details
Table Merck Revenue in Retinal Disease Therapeutics Business 2014-2019 (Million US$)
Figure Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Retinal Disease Therapeutics Business 2014-2019 (Million US$)
Figure Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2014-2019)
Table Novartis Recent Development
Table Allergan Company Details
Table Allergan Revenue in Retinal Disease Therapeutics Business 2014-2019 (Million US$)
Figure Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2014-2019)
Table Allergan Recent Development
Table Roche Company Details
Table Roche Revenue in Retinal Disease Therapeutics Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2014-2019)
Table Roche Recent Development
Table Regeneron Company Details
Table Regeneron Revenue in Retinal Disease Therapeutics Business 2014-2019 (Million US$)
Figure Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2014-2019)
Table Regeneron Recent Development
Table Santen Company Details
Table Santen Revenue in Retinal Disease Therapeutics Business 2014-2019 (Million US$)
Figure Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2014-2019)
Table Santen Recent Development
Table Global Retinal Disease Therapeutics Market Size by Regions (Million US$) 2019-2025
Figure Global Retinal Disease Therapeutics Market Size Share by Regions (2019-2025)
Figure Global Retinal Disease Therapeutics Market Size Share by Regions in 2025
Figure North America Retinal Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Retinal Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Figure Asia-Pacific Retinal Disease Therapeutics Market Size Forecast (2019-2025)(Million USD)
Table Global Retinal Disease Therapeutics Market Size by Product (2019-2025) (Million US$)
Figure Global Retinal Disease Therapeutics Market Size by Product (2019-2025)
Figure Global Retinal Disease Therapeutics Market Size by Product in 2025
Table Global Retinal Disease Therapeutics Market Size by Application (2019-2025) (Million US$)
Figure Global Retinal Disease Therapeutics Market Size by Application (2019-2025)
Figure Global Retinal Disease Therapeutics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Merck、Novartis、Allergan、Roche、Regeneron、Santen

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 網膜疾患治療薬の世界市場：規模・現状・予測(Global Retinal Disease Therapeutics Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp